Related Experiment Videos
Hypocholesterolemia, an unfavorable feature of prognostic value in chronic myeloid leukemia
C P Muller1, A U Wagner, C Maucher
1University Medical Clinic II, Tübingen, Fed. Rep. Germany.
Insights
Low serum cholesterol is linked to chronic myeloid leukemia (CML) activity. Higher cholesterol levels correlate with improved survival and longer disease duration in CML patients.
Area of Science:
- Hematology
- Oncology
- Biochemistry
Background:
- Low serum cholesterol is frequently observed in chronic myeloid leukemia (CML).
- The association between serum cholesterol and CML disease activity is recognized.
- Cholesterol has been largely overlooked as a prognostic marker in CML research.
Purpose of the Study:
- To investigate the prognostic significance of serum cholesterol levels in patients with chronic myeloid leukemia.
- To determine if cholesterol can serve as an independent prognostic factor in CML.
Main Methods:
- Univariate analysis was performed to assess the correlation between cholesterol and survival/disease duration.
- Multivariate Cox regression modeling was employed to identify independent prognostic parameters.
- Key clinical and laboratory parameters including cholesterol, myeloblasts, sex, eosinophilia, and LDH were analyzed.
Main Results:
- Serum cholesterol showed a significant positive correlation with survival (p = 0.0012) in univariate analysis.
- Cholesterol also correlated positively with the duration of the chronic phase (p = 0.0059).
- In the multivariate Cox regression model, cholesterol was identified as a significant additive prognostic factor.
Conclusions:
- Serum cholesterol level is a valuable prognostic indicator in chronic myeloid leukemia.
- Cholesterol provides additive prognostic information alongside established factors like marrow myeloblasts, sex, eosinophilia, and lactate dehydrogenase.
- Incorporating cholesterol assessment may improve prognostic accuracy and patient management in CML.
Abstract:
In chronic myeloid leukemia (CML) low serum cholesterol is not uncommon and has been linked to the activity of the disease. Despite these observations, most studies concerned with prognostic signs in CML have not included cholesterol. In our study, cholesterol correlated positively with survival (p = 0.0012) and with the duration of chronic phase (p = 0.0059) in a univariate analysis. The multivariate Cox regression model selected cholesterol as a parameter of additive prognostic value in addition to marrow myeloblasts plus promyelocytes, sex, eosinophilia and lactate dehydrogenase.